Page 6 - Monitoring Management News Today

Article content Study Stresses the Importance of Brain Monitoring During the Treatment of Patients with Severe COVID-19 NEUCHATEL, Switzerland — Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Critical Care in which researchers in Genoa, Italy, evaluated the impact of a variety of rescue therapies on the systemic and cerebral oxygenation of mechanically ventilated COVID-19 patients suffering from acute respiratory distress syndrome (ARD...

Masimo New Study Evaluates the Ability of Masimo EMMA® Capnography to Assess the Respiratory Status of Children With Tracheostomy Monday, March 15, 2021 1:12PM IST (7:42AM GMT)   Masimo (NASDAQ: MASI) today announced the findings of an observational, retrospective study published in Pediatrics International. In the study, researchers at the Osaka Women’s and Children’s Hospital in Japan found the Masimo EMMA ® Portable Capnograph “useful for assessment of the respiratory condition in ...

Masimo (NASDAQ: MASI) today announced the findings of an observational, retrospective study published in Pediatrics International. In the study, researchers at the Osaka Women’s and Children’s Hospital in Japan found the Masimo EMMA ® Portable Capnograph “useful for assessment of the respiratory condition in children with tracheostomy.” 1 EMMA ® provides seamless mainstream capnography for patients of all ages in a compact, easily portable device. The device requires no routine calib...

Masimo Announces CE Marking of the Rad-G™ with Temperature Tuesday, March 2, 2021 1:26PM IST (7:56AM GMT)   Neuchatel, Switzerland:   Masimo (NASDAQ: MASI) today announced the CE marking of the Rad-G™ with Temperature, a rugged handheld device that provides clinically proven SET ® pulse oximetry, respiration rate from the pleth (RRp ®), and other important parameters alongside clinical-grade, non-contact infrared thermometry. W...

Masimo Expands Suite of Advanced Measurements Through Acquisition of UK-Based LiDCO Group Plc Masimo Expands Suite of Advanced Measurements Through Acquisition of UK-Based LiDCO Group Plc Masimo (NASDAQ: MASI) today announced that it has successfully completed the acquisition of the LiDCO Group Plc, a leading provider of advanced hemodynamic monitoring solutions (LiDCO). The Company completed the acquisition of 100% of LiDCO on February 2, 2021. LiDCO was founded in 1991, launched its first p...

Masimo Announces Full Market Release of Masimo SafetyNet-OPEN™ Masimo (NASDAQ: MASI) today announced the full market release of Masimo SafetyNet-OPEN (News - Alert)™, a web and mobile app solution that helps businesses, schools, and other organizations screen, trace, and manage users as they face COVID-19 and other infectious illnesses, such as seasonal flu. SafetyNet-OPEN not only helps organizations bring their people back to the workplace responsibly, but stay open safely. Tailored for ...

New Study Associates Masimo SpHb, Noninvasive and Continuous Hemoglobin Monitoring, as Part of Pediatric Patient Blood Management, with Reduced ICU Stays and Postoperative Transfusion 55.43 hours 25.34 hours (48 hours median) 33.48 hours 12.25 hours (24 hours median) 0.001 179.02 mL 163.06 mL (145 mL) 102.69 mL 73.87 mL (105 mL) 0.033 71.96 mL 94.95 mL (25 mL) 28.15 mL 64.35 mL (0 mL) 0.043 462.59 mL 158.91 mL (500 mL) 0.048 270,821 74,474 1.47 mmol/L 0.64 mmol/L (1.25 mmol/L) 1.18 mmol/L 0.63 ...

Masimo New Study Associates Masimo SpHb®, Noninvasive and Continuous Hemoglobin Monitoring, as Part of Pediatric Patient Blood Management, with Reduced ICU Stays and Postoperative Transfusion Thursday, December 10, 2020 2:34PM IST (9:04AM GMT)   Masimo (NASDAQ: MASI) announced today the findings of an abstract recently presented at Euroanaesthesia 2020 in which Dr. Saraçoğlu and colleagues at Marmara University in Istanbul, Turkey investigated the efficacy of Masimo noninvasive and continu...